Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Nu-Med Plus (NUMD) Shares Outstanding (Diluted Average) (2016 - 2021)

Nu-Med Plus' Shares Outstanding (Diluted Average) history spans 5 years, with the latest figure at $79.3 million for Q3 2021.

  • Quarterly results put Shares Outstanding (Diluted Average) at $79.3 million for Q3 2021, changed N/A from a year ago — trailing twelve months through Sep 2021 was $79.3 million (changed N/A YoY), and the annual figure for FY2018 was $41.8 million, down 41.85%.
  • Shares Outstanding (Diluted Average) for Q3 2021 was $79.3 million at Nu-Med Plus, roughly flat from $79.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $79.3 million in Q3 2021 to a low of $37.6 million in Q1 2018.
  • The 3-year median for Shares Outstanding (Diluted Average) is $73.6 million (2017), against an average of $61.3 million.
  • The sharpest move saw Shares Outstanding (Diluted Average) soared 100.9% in 2017, then tumbled 50.36% in 2018.
  • Year by year, Shares Outstanding (Diluted Average) stood at $71.9 million in 2017, then crashed by 41.85% to $41.8 million in 2018, then soared by 89.9% to $79.3 million in 2021.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $79.3 million, $79.3 million, and $41.8 million for Q3 2021, Q2 2021, and Q4 2018 respectively.